证券代码：002899 证券简称：英派斯 青岛英派斯健康科技股份有限公司 投资者关系活动记录表 编号：2023-001 答:投资者您好，由于项目单体建筑物的跨度大、高 度高，有部分属于重工，因此对混凝土强度的要求较高。 同时，在主体施工过程中，市场的材料价格存在增长，受 近两年外部环境的影响，运输成本也有所增加，因此产业 园车间的造价较高，感谢您的关注！ 3、问：公司负债情况如何？ 答:投资者：您好，我公司目前负债主要为银行长期 借款，用于新工业园建设。正在积极进行定增。目前资产 负责率为 42.85%。公司债务还本付息能力充足。感谢您 的关注！ 4、问：公司新的产业园建设进度是什么样，预计什么时 间投入使用 答:投资者：您好！公司新产业园拟于 2023 年 9 月 30 日前完成搬迁，生产线投产。感谢您的关注。 5、问：请问董秘，贵公司有海外拓展业务的计划吗 答:投资者您好，我司一直很重视海外市场的拓展， 根据 2022 年年度报告，公司国外销售收入 61348.99 万元， 占营业收入的比例为 74.39%，较去年同期上升 8.34%。感 谢您的关注! 6、问：今年是疫情结束后的第一年，公司项目中标情况 ...

证券代码：002899 证券简称：英派斯 公告编号：2023-044 董事会 2023 年 5 月 17 日 青岛英派斯健康科技股份有限公司（以下简称"公司"）定于 2023 年 5 月 24 日（星期三）15:00-17:00 在同花顺网上路演互动平台举办 2022 年度业绩 说明会，本次年度业绩说明会将采用网络远程的方式举行，投资者可登陆"同 花顺路演平台"（https://board.10jqka.com.cn/ir）或同花顺 App 端入口（同花顺 App 首页-搜索-路演平台）参与本次年度业绩说明会。 出席本次说明会的人员有：公司董事长刘洪涛先生，公司董事、总经理文 珂先生，公司独立董事徐国君先生，公司财务负责人韩玉梅女士，公司副总经 理、董事会秘书张瑞女士。 为充分尊重投资者、提升交流的针对性，现就公司 2022 年度业绩说明会提 前向投资者公开征集问题，广泛听取投资者的意见和建议。投资者可于 2023 年 5 月 22 日（星期一）16：00 前通过上述方式提前进入英派斯路演厅进行提 问。届时公司将在 2022 年度业绩说明会上，对投资者普遍关注的问题进行回答。 欢迎广大投资者积极参与本次业绩说 ...

青岛英派斯健康科技股份有限公司 2023 年第一季度报告 证券代码：002899 证券简称：英派斯 公告编号：2023-038 青岛英派斯健康科技股份有限公司 2023 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 重要内容提示： 1、董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2、公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3、第一季度报告是否经审计 □是 ☑否 1 青岛英派斯健康科技股份有限公司 2023 年第一季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 ☑否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | | | | （%） | | 营业收入（元） | 198,895,446.90 | 194,236,771.71 | 2.40% | | ...

Financial Performance - The company's operating revenue for 2022 was ¥824,696,742.37, a decrease of 4.59% compared to ¥864,394,696.17 in 2021[19]. - Net profit attributable to shareholders for 2022 was ¥65,664,553.48, representing a significant increase of 276.69% from ¥17,431,898.78 in 2021[19]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥41,210,455.41, up 32.06% from ¥31,206,585.33 in 2021[19]. - The basic and diluted earnings per share for 2022 were both ¥0.55, reflecting a 266.67% increase from ¥0.15 in 2021[19]. - The total revenue for 2022 was approximately ¥824.70 million, a decrease of 4.59% compared to ¥864.39 million in 2021[62]. - Sales of sports fitness products accounted for 99.72% of total revenue, totaling approximately ¥822.39 million, down 4.61% from ¥862.15 million in the previous year[62]. - The gross profit margin for sports fitness products was 26.24%, a slight increase of 0.62% compared to the previous year[63]. - The company reported a significant decline in sales of home fitness products, which dropped by 33.32% to approximately ¥7.55 million[62]. - The total sales revenue for commercial products reached ¥735.6 million, an increase of 26.83% compared to the previous year[64]. - The company reported a significant increase in tax refunds received, contributing to the improved net cash flow from operating activities[76]. Assets and Liabilities - The total assets at the end of 2022 were ¥2,029,945,060.50, an increase of 14.21% from ¥1,777,354,150.65 at the end of 2021[20]. - The net assets attributable to shareholders at the end of 2022 were ¥1,160,132,904.97, a rise of 5.74% from ¥1,097,108,351.49 at the end of 2021[20]. - As of the end of 2022, cash and cash equivalents decreased by 17.37% to ¥387,246,958.74, accounting for 19.08% of total assets[80]. - Accounts receivable increased to ¥162,863,709.09, representing 8.02% of total assets, with no significant changes reported[80]. - Long-term borrowings rose by 3.75% to ¥535,373,539.58, which is 26.37% of total liabilities, with no major changes noted[81]. Market and Growth Strategies - The company is positioned to benefit from favorable government policies promoting the sports industry and "Internet + fitness" trends, which are expected to drive growth[30]. - The company plans to enhance its market presence and product offerings in response to the increasing demand for fitness-related services and products[30]. - The domestic fitness equipment market is expected to see significant growth in demand for home fitness equipment due to rising living standards and fitness awareness[40]. - The company has successfully established a retail network combining distribution and direct sales across the country, enhancing service and responsiveness[33]. - The company is actively exploring e-commerce channels to attract a broader customer base and expand market reach[39]. - The company aims to expand its market presence through innovative product development and strategic partnerships[70]. - The company plans to enhance its overseas OEM/ODM product export business, aiming for greater cooperation with existing clients and exploring new high-value product projects[105]. - The company plans to expand its market presence in Southeast Asia, targeting a 30% increase in international sales by 2024[138]. Research and Development - The R&D team consists of 53 members, with 32 having over 10 years of experience in the fitness equipment industry, ensuring a deep understanding of market trends[55]. - The company holds 306 valid domestic patents, including 27 invention patents, and has acquired 44 new domestic patents during the reporting period[55]. - The company is developing a new home fitness brand "WeSwag," with initial product offerings including treadmills and exercise bikes[46]. - The company is developing a series of pneumatic resistance training devices aimed at enhancing performance while minimizing injury risk, expected to boost future sales[70]. - The company is focusing on enhancing its digital marketing strategies, aiming for a 40% increase in online sales channels[138]. Corporate Governance and Management - The company has established a fair and transparent performance evaluation and incentive mechanism for directors, supervisors, and senior management, aligning the interests of shareholders, the company, and the incentive targets[121]. - The company held its annual general meeting with a participation rate of 24.21% on June 8, 2022, and the first extraordinary general meeting with a participation rate of 22.39% on September 14, 2022[126][127]. - The company experienced a change in leadership with Liu Hongtao being elected as the Chairman on August 29, 2022, due to company work adjustments[131]. - The company has undergone significant management changes in 2022, impacting its strategic direction[132]. - The board of directors approved the appointment of Wenke as a director on September 14, 2022[130]. Environmental and Social Responsibility - The company has implemented environmental protection measures, ensuring compliance with national regulations on waste management and emissions[181]. - The company has actively participated in social welfare initiatives, sponsoring various sports events and educational programs to support community development[181]. - The company has established emergency response plans for environmental incidents, which have been approved by environmental experts[177]. - The company has conducted quarterly monitoring of wastewater and emissions, ensuring compliance with environmental standards[176]. Risks and Challenges - The company faces risks from exchange rate fluctuations, which could negatively impact profits, and plans to adjust sales prices in contracts to mitigate these risks[112]. - Rising raw material prices, particularly for steel and packaging materials, have significantly affected production costs, prompting the company to enhance internal management and seek cost-effective alternatives[113]. - The company is exposed to risks from international trade policies affecting its export business, and it is optimizing its customer structure to mitigate these risks[114].

证券代码：002899 证券简称：英派斯 青岛英派斯健康科技股份有限公司投资者关系活动记录表 编号：2019-001 | --- | --- | --- | |----------------|------------------------------|---------------------------------------------------------------| | | | | | 投资者关系活动 | □ 特定对象调研 □分析师会议 | | | 类别 | □ 媒体采访 √业绩说明会 | | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | | □其他 （请文字说明其他活动内容） | | 参与单位名称及 | 面向所有关注我司的投资者 | | | 人员姓名 | | | | 时间 | 2019 年 5 月 14 日 | 15： 00-17：00 | | 地点 | 青岛市崂山区秦岭路 | 18 号 3 号楼 7 层公司会议室 | | 上市公司接待人 | | 董事长兼总经理丁利荣先生、财务负责人朱英华女士、董事 | | 员姓名 | | 会秘书兼副总经理张瑞女士、独立董 ...

证券代码：002899 证券简称：英派斯 青岛英派斯健康科技股份有限公司投资者关系活动记录表 编号：2018-001 | --- | --- | --- | |----------------|-----------------------------|------------------------------------------------------------| | | | | | 投资者关系活动 | □ | 特定对象调研 □分析师会议 | | 类别 | □ 媒体采访 √业绩说明会 | | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | | □其他 （请文字说明其他活动内容） | | 参与单位名称及 | 面向所有关注我司的投资者 | | | 人员姓名 | | | | 时间 | 2018 年 5 月 4 日 | 15：00-17：00 | | 地点 | 青岛市崂山区秦岭路 | 18 号 3 号楼 7 层公司会议室 | | 上市公司接待人 | | 董事长兼总经理丁利荣先生、财务负责人朱英华女士、董事 | | 员姓名 | | 会秘书兼副总经理张瑞女士、独立董事梁仕念先生 ...

证券代码：002899 证券简称：英派斯 青岛英派斯健康科技股份有限公司投资者关系活动记录表 编号：2021-001 | --- | --- | --- | --- | --- | --- | |----------------|----------------------------------|--------------------------------------------------------|--------------------------------------------------------|-------|----------------| | | | | | | | | 投资者关系活动 | □ 特定对象调研 | 分析师会议 | □ | | | | 类别 | □ 媒体采访 | 业绩说明会 | √ | | | | | □ 新闻发布会 | 路演活动 | □ | | | | | □ 现场参观 | | | | | | | □ 其他 | | （请文字说明其他活动内容） | | | | | | | | | | | 参与单位名称及 | | | 通过全景网投资者关系互动平台及同花顺网上路演互动 ...

Group 1: Impact of COVID-19 on Business - The pandemic has had both positive and negative effects on the company. On the positive side, it has increased public awareness of fitness and health, leading to a rise in demand for home fitness products [1][2] - The negative impact includes the closure or delayed opening of many commercial gyms due to the pandemic, but the company believes opportunities outweigh challenges in the long run [2] Group 2: Market Development and Product Strategy - The company has made significant preparations in the home product sector, increasing investment in research, production, and sales channels for home fitness products [2] - The company has established flagship stores on e-commerce platforms like Taobao, Tmall, and JD.com, and plans to explore new online promotion methods to enhance product visibility [2] Group 3: Targeting Specific Demographics - The company has developed the RE-LIFE series of products specifically for the elderly, focusing on safety and ease of use with hydraulic resistance adjustments [2] - The elderly market is seen as a significant opportunity due to the increasing aging population [2] Group 4: Sales Distribution - In 2020, domestic sales accounted for 25.90% of total sales, while international sales made up 74.10%, indicating a strong reliance on overseas markets [3] - North America, Europe, and Asia-Pacific are the top three international markets, with North America and Europe being mature markets and Asia-Pacific showing faster growth potential [3] Group 5: Profitability Challenges - The decline in net profit in recent years is attributed to high R&D investments and rising production costs, particularly due to increased raw material prices [4] - The company plans to enhance profitability by adjusting its product offerings to capture domestic market opportunities and improving production efficiency through new facilities [4] Group 6: Brand Promotion Strategies - The company emphasizes brand promotion through various media channels, including traditional and digital platforms, to build brand awareness and attract potential customers [4] - It has also adapted to the pandemic by focusing on online channels and successfully entering international platforms like Alibaba and Google for broader market reach [4] Group 7: Raw Material Price Impact - Rising raw material costs, particularly for steel, have pressured the company's cost management, but it has implemented measures to mitigate these effects, including price adjustment mechanisms with clients [4] - The company monitors exchange rates for export products and adjusts sales prices accordingly to minimize losses from currency fluctuations [4] Group 8: R&D and Innovation - The company recognizes the importance of innovation and R&D in maintaining competitive advantage, focusing on market demand and technological integration [5] - It conducts regular market research to anticipate product updates and actively invests in R&D to drive continuous development [5]

证券代码：002899 证券简称：英派斯 青岛英派斯健康科技股份有限公司投资者关系活动记录表 编号：2021-003 | --- | --- | --- | --- | |-----------------------------|-------------------------------------|-------------------------------------------------------------------|------------------| | | | | | | 投资者关系活动 | √ 特定对象调研 □ | 分析师会议 | | | 类别 | □ 媒体采访 □ | 业绩说明会 | | | | □ 新闻发布会 □ | 路演活动 | | | | □ 现场参观 | | | | | □ 其他 | （请文字说明其他活动内容） | | | | | | | | 参与单位名称 | | 申万宏源，南方基金，中庚基金，民生加银等 | | | | | | | | 时间 | 2021 年 9 月 9 日 | | | | 地点 | 电话会议 | | | | 上市公司接待人 员姓名 | 董事会秘书 ...

[Major Financial Data](index=1&type=section&id=Major%20Financial%20Data) This section provides an overview of the company's key financial performance indicators, non-recurring gains and losses, and detailed analysis of significant financial statement changes [Key Accounting Data and Financial Indicators](index=1&type=section&id=Key%20Accounting%20Data%20and%20Financial%20Indicators) The company reported a slight revenue increase in Q3 2022, while year-to-date revenue declined, with significant Q3 net profit growth driven by cost control and exchange gains, and total assets increasing by 6.23% | Indicator | Current Period (Q3 2022) | Year-to-Date (YTD Q3 2022) | YTD Change vs. Prior Year (%) | | :--- | :--- | :--- | :--- | | Operating Revenue (RMB) | 190.13 million | 567.19 million | -9.65% | | Net Profit Attributable to Parent Company Shareholders (RMB) | 14.10 million | 29.59 million | 5.22% | | Net Profit Attributable to Parent Company Shareholders (Excluding Non-recurring Items) (RMB) | 12.69 million | 25.78 million | -4.07% | | Net Cash Flow from Operating Activities (RMB) | — | -24.84 million | 27.11% | | Basic Earnings Per Share (RMB/share) | 0.12 | 0.25 | 8.70% | | Total Assets (RMB) | 1.89 billion | 1.78 billion (Prior Year-End) | 6.23% (vs. Prior Year-End) | | Owners' Equity Attributable to Parent Company Shareholders (RMB) | 1.12 billion | 1.10 billion (Prior Year-End) | 2.46% (vs. Prior Year-End) | - Q3 single-quarter revenue increased by **4.01%** year-on-year, but cumulative revenue for the first three quarters decreased by **9.65%** year-on-year, indicating a business recovery in Q3[3](index=3&type=chunk) - Q3 single-quarter net profit attributable to the parent company significantly increased by **66.57%** year-on-year, driving a **5.22%** year-on-year cumulative growth in net profit attributable to the parent company for the first three quarters[3](index=3&type=chunk) [Non-recurring Gains and Losses and Amounts](index=2&type=section&id=Non-recurring%20Gains%20and%20Losses%20and%20Amounts) In the first three quarters of 2022, the company's non-recurring gains and losses totaled **3.82 million RMB**, mainly from government grants and financial asset fair value changes, positively impacting profit | Item | Year-to-Date Amount (RMB) | | :--- | :--- | | Government Grants | 4.04 million | | Gains/Losses from Transactional Financial Assets | 0.73 million | | Gains/Losses from Disposal of Non-current Assets | -0.03 million | | Other Non-operating Income/Expenses | -0.25 million | | Income Tax Impact | -0.67 million | | **Total** | **3.82 million** | [Analysis of Changes in Key Financial Indicators and Their Causes](index=2&type=section&id=Analysis%20of%20Changes%20in%20Key%20Financial%20Indicators%20and%20Their%20Causes) Significant changes in financial indicators include a **43.85%** decrease in cash due to industrial park construction, a **37.41%** increase in long-term borrowings, a **41.54%** decrease in selling expenses due to reclassification, and a **779.16%** reduction in financial expenses from exchange gains - The ongoing construction of the 'Qingdao Impetus Sports Industrial Park' is the primary reason for changes in multiple balance sheet items, including decreased cash and cash equivalents, increased construction in progress, increased other non-current assets (prepaid engineering costs), and increased long-term borrowings[7](index=7&type=chunk)[8](index=8&type=chunk) - Selling expenses significantly decreased by **41.54%** year-on-year, primarily due to accounting reclassification of freight and comprehensive service fees into cost of goods sold under new regulations[8](index=8&type=chunk) - Financial expenses significantly decreased by **779.16%** year-on-year, mainly due to increased exchange gains during the period[8](index=8&type=chunk) - Net cash outflow from investing activities increased by **38.42%** year-on-year, primarily due to increased cash payments for the acquisition of fixed assets (industrial park construction) and investment in wealth management products[8](index=8&type=chunk) [Shareholder Information](index=4&type=section&id=Shareholder%20Information) This section details the company's common shareholding structure, including the total number of shareholders and the top ten shareholders' holdings [Common Shareholding Status](index=4&type=section&id=Total%20Number%20of%20Common%20Shareholders%20and%20Preferred%20Shareholders%20with%20Restored%20Voting%20Rights%20and%20Top%20Ten%20Shareholders'%20Shareholding%20Table) As of the reporting period end, the company had **14,319** common shareholders, with the largest shareholder holding **33.89%** and approximately half of their shares pledged, while two top ten shareholders are concerted parties - The total number of common shareholders at the end of the reporting period was **14,319**[10](index=10&type=chunk) | Shareholder Name | Shareholding Percentage | Number of Shares Held | Number of Pledged Shares | | :--- | :--- | :--- | :--- | | Hainan Jiangheng Industrial Investment Co., Ltd. | 33.89% | 40,662,000 | 20,229,900 | | Yinfu China Investment Co., Ltd. | 3.90% | 4,677,800 | - | | Nantong Deyu Investment Center (Limited Partnership) | 3.39% | 4,062,300 | - | - Shareholders Hunan Cultural Tourism Venture Capital Investment Fund Enterprise (Limited Partnership) and Yinfu China Investment Co., Ltd. are concerted parties[10](index=10&type=chunk) [Other Significant Matters](index=5&type=section&id=Other%20Significant%20Matters) During the reporting period, the company and several subsidiaries changed legal representatives from Ding Lirong to Liu Hongtao, indicating a significant management adjustment - From September to October 2022, the legal representative of several subsidiaries, including the parent company Qingdao Impetus Health Technology Co., Ltd., changed from Ding Lirong to Liu Hongtao[12](index=12&type=chunk) [Quarterly Financial Statements](index=5&type=section&id=Quarterly%20Financial%20Statements) This section presents the company's consolidated balance sheet, income statement, and cash flow statement for the reporting period [Consolidated Balance Sheet](index=5&type=section&id=1.%20Consolidated%20Balance%20Sheet) As of September 30, 2022, total assets reached **1.89 billion RMB** (+**6.23%**), with cash decreasing and construction in progress increasing due to industrial park development, while total liabilities rose to **0.76 billion RMB** | Key Balance Sheet Items | September 30, 2022 (RMB) | January 1, 2022 (RMB) | Change (%) | | :--- | :--- | :--- | :--- | | Cash and Cash Equivalents | 363.75 million | 647.76 million | -43.85% | | Construction in Progress | 555.10 million | 377.03 million | 47.23% | | Long-term Borrowings | 552.55 million | 402.12 million | 37.41% | | **Total Assets** | **1.89 billion** | **1.78 billion** | **6.23%** | | **Total Liabilities** | **763.94 million** | **680.25 million** | **12.30%** | | **Total Owners' Equity** | **1.12 billion** | **1.10 billion** | **2.46%** | [Consolidated Income Statement (Year-to-Date)](index=7&type=section&id=2.%20Consolidated%20Income%20Statement%20(Year-to-Date)) In the first three quarters of 2022, operating revenue decreased by **9.65%** to **0.57 billion RMB**, yet net profit attributable to the parent company increased by **5.22%** to **29.59 million RMB** due to cost control and exchange gains | Key Income Statement Items | Current Period Amount (YTD Q3 2022) | Prior Period Amount (YTD Q3 2021) | Change (%) | | :--- | :--- | :--- | :--- | | Total Operating Revenue | 567.19 million | 627.75 million | -9.65% | | Operating Cost | 433.02 million | 434.16 million | -0.26% | | Selling Expenses | 45.37 million | 77.60 million | -41.54% | | Financial Expenses | -19.26 million | -2.19 million | -779.16% | | Operating Profit | 32.31 million | 31.99 million | 0.99% | | Net Profit Attributable to Parent Company Shareholders | 29.59 million | 28.12 million | 5.22% | [Consolidated Cash Flow Statement (Year-to-Date)](index=9&type=section&id=3.%20Consolidated%20Cash%20Flow%20Statement%20(Year-to-Date)) In the first three quarters of 2022, operating cash flow remained negative at **-24.84 million RMB**, investing cash outflow significantly increased to **-0.39 billion RMB** due to industrial park construction, and financing cash inflow decreased, leading to a **0.28 billion RMB** net reduction in cash | Key Cash Flow Items | Current Period Amount (YTD Q3 2022) | Prior Period Amount (YTD Q3 2021) | Change (%) | | :--- | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | -24.84 million | -34.08 million | 27.11% | | Net Cash Flow from Investing Activities | -390.55 million | -282.14 million | -38.42% | | Net Cash Flow from Financing Activities | 120.45 million | 395.15 million | -69.52% | | Net Increase in Cash and Cash Equivalents | -283.95 million | 78.31 million | -462.58% | [Audit Opinion](index=10&type=section&id=Audit%20Report) The company's Q3 2022 report is unaudited - The company's third-quarter report is unaudited[25](index=25&type=chunk)